“Plaquenil is used with the patients of medium, intensive, and very intensive severity of the condition” – told the Director of Tbilisi Infectious Disease Hospital, Tengiz Tsertsvadze to journalists after the doctors’ meeting.
Plaquenil, the popular medicament used according to the protocol, was also discussed during the meeting. The medicament will remain in the Georgian protocol, and remain according to the protocol indication and not according to the interpretations of its used proposed by some of the doctors. It is prescribed for the patientsof the medium, intensive, and very intensive severity of the condition. The categorization is given by the FDA, the most authoritative and, actually, the highest stage instance that decides on the use of medicaments for various diseases. The hope-giving medicine to cure COVID-19 infection of the last period, Remdesivir, failed to meet the expectations in terms of its efficiency. There are plenty of mutually exclusive considerations advertised in the last period. FDA considers Plaqfenil in its protocol, and we will follow it.” – Tengiz Tsertsvadze said.
